Nightingale Health Oyj B
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blo… Read more
Nightingale Health Oyj B (HEALTH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.153x
Based on the latest financial reports, Nightingale Health Oyj B (HEALTH) has a cash flow conversion efficiency ratio of -0.153x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-10.11 Million) by net assets (€66.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nightingale Health Oyj B - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Nightingale Health Oyj B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nightingale Health Oyj B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nightingale Health Oyj B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
YASHO INDUSTRIES ORD (BSE)
NSE:YASHO
|
0.011x |
|
Durect Corporation
NASDAQ:DRRX
|
-0.447x |
|
Daesung Energy
KO:117580
|
-0.031x |
|
Village Bank and Trust Financial
NASDAQ:VBFC
|
-0.037x |
|
ETHZilla Corporation
NASDAQ:ETHZ
|
-0.037x |
|
NANOFORM FINLAND OYJ
F:4YL
|
N/A |
|
RESEARCH SOLUTIONS DL-001
F:61I
|
N/A |
|
Gabriel Holding A/S
F:1GH
|
0.144x |
Annual Cash Flow Conversion Efficiency for Nightingale Health Oyj B (2020–2025)
The table below shows the annual cash flow conversion efficiency of Nightingale Health Oyj B from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | €66.17 Million | €-10.11 Million | -0.153x | -50.59% |
| 2024-06-30 | €82.88 Million | €-8.41 Million | -0.101x | -34.76% |
| 2023-06-30 | €97.36 Million | €-7.33 Million | -0.075x | -12.25% |
| 2022-06-30 | €111.44 Million | €-7.47 Million | -0.067x | -340.81% |
| 2021-06-30 | €123.04 Million | €-1.87 Million | -0.015x | +95.80% |
| 2020-06-30 | €8.73 Million | €-3.17 Million | -0.362x | -- |